Historique
Rapport
WHO expert committee on drug dependence. 40th report
Auteur(s) :
OMS / WHO (Organisation mondiale de la santé / World Health Organization) ;
Expert Committee on Drug Dependence, Fortieth Meeting (4-7 June 2018; Geneva)
Année
2018
Page(s) :
60 p.
Langue(s) :
Anglais
Éditeur(s) :
Genève : OMS / WHO
Collection :
Rapports techniques / Technical report series, 1013
ISBN :
978-92-4-121022-5
Refs biblio. :
6
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
INTERNATIONAL
Thésaurus mots-clés
RECOMMANDATION
;
CONTROLE DES STUPEFIANTS
;
DROIT INTERNATIONAL
;
DROGUES DE SYNTHESE
;
POTENTIEL ADDICTIF
;
CANNABINOIDES
;
CANNABIS
;
TOXICOLOGIE
;
PHARMACOLOGIE
;
TETRAHYDROCANNABINOL
Note de contenu :
CONTENTS:
1. Introduction.
2. WHO Expert Committee on Drug Dependence (ECDD): review procedures and processes.
3. Open session.
4. Briefings from international organizations on their work on the public health dimension of the world drug problem.
5. Review of substances.
6. Cannabidiol.
7. Cannabis and cannabis resin.
8. Extracts and tinctures of cannabis.
9. Delta-9-tetrahydrocannabinol (Delta9-THC; dronabinol).
10. Tetrahydrocannabinol (Isomers of THC).
1. Introduction.
2. WHO Expert Committee on Drug Dependence (ECDD): review procedures and processes.
3. Open session.
4. Briefings from international organizations on their work on the public health dimension of the world drug problem.
5. Review of substances.
6. Cannabidiol.
7. Cannabis and cannabis resin.
8. Extracts and tinctures of cannabis.
9. Delta-9-tetrahydrocannabinol (Delta9-THC; dronabinol).
10. Tetrahydrocannabinol (Isomers of THC).
Résumé :
This report presents the recommendations of the fortieth WHO Expert Committee on Drug Dependence (ECDD). The ECDD is responsible for the assessment of psychoactive substances for possible scheduling under the International Drug Control Conventions. The ECDD reviews the therapeutic usefulness, the liability for abuse and dependence, and the public health and social harm of each substance. The ECDD will advise the Director-General of WHO, to schedule or to amend the scheduling status of a substance. The Director-General will, as appropriate, communicate the recommendations to the Secretary-General of the United Nations, who will in turn communicate the advice to the Commission on Narcotic Drugs (CND).
The report summarizes the findings of the fortieth meeting, which was dedicated to the review of cannabis and its component substances. This included a critical review of cannabidiol and pre-reviews of cannabis plant and resin; extracts and tinctures of cannabis; Delta9-tetrahydrocannabinol (Delta9-THC); and isomers of THC. The Committee recommended that preparations considered to be pure cannabidiol should not be scheduled within the International Drug Control Conventions. The Committee concluded that there is sufficient evidence to proceed to a critical review of cannabis plant and resin; extracts and tinctures of cannabis; Delta9-THC and isomers of Delta9-THC.
The report summarizes the findings of the fortieth meeting, which was dedicated to the review of cannabis and its component substances. This included a critical review of cannabidiol and pre-reviews of cannabis plant and resin; extracts and tinctures of cannabis; Delta9-tetrahydrocannabinol (Delta9-THC); and isomers of THC. The Committee recommended that preparations considered to be pure cannabidiol should not be scheduled within the International Drug Control Conventions. The Committee concluded that there is sufficient evidence to proceed to a critical review of cannabis plant and resin; extracts and tinctures of cannabis; Delta9-THC and isomers of Delta9-THC.